329 related articles for article (PubMed ID: 36171094)
21. Interplay between compartmentalized NAD
Cohen MS
Genes Dev; 2020 Mar; 34(5-6):254-262. PubMed ID: 32029457
[TBL] [Abstract][Full Text] [Related]
22. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
[TBL] [Abstract][Full Text] [Related]
23. PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.
Lloret A; Beal MF
Neurochem Res; 2019 Oct; 44(10):2423-2434. PubMed ID: 31065944
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms governing PARP expression, localization, and activity in cells.
Sanderson DJ; Cohen MS
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
[TBL] [Abstract][Full Text] [Related]
25. Clickable NAD analogues for labeling substrate proteins of poly(ADP-ribose) polymerases.
Jiang H; Kim JH; Frizzell KM; Kraus WL; Lin H
J Am Chem Soc; 2010 Jul; 132(27):9363-72. PubMed ID: 20560583
[TBL] [Abstract][Full Text] [Related]
26. The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis.
Podyacheva E; Toropova Y
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175631
[TBL] [Abstract][Full Text] [Related]
27. Biosensor reveals multiple sources for mitochondrial NAD⁺.
Cambronne XA; Stewart ML; Kim D; Jones-Brunette AM; Morgan RK; Farrens DL; Cohen MS; Goodman RH
Science; 2016 Jun; 352(6292):1474-7. PubMed ID: 27313049
[TBL] [Abstract][Full Text] [Related]
28. Role of Nuclear NAD
Brown EE; Scandura MJ; Pierce E
Adv Exp Med Biol; 2023; 1415():235-239. PubMed ID: 37440039
[TBL] [Abstract][Full Text] [Related]
29. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?
Zhang J
Bioessays; 2003 Aug; 25(8):808-14. PubMed ID: 12879452
[TBL] [Abstract][Full Text] [Related]
30. TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
Ugamraj HS; Dang K; Ouisse LH; Buelow B; Chini EN; Castello G; Allison J; Clarke SC; Davison LM; Buelow R; Deng R; Iyer S; Schellenberger U; Manika SN; Bijpuria S; Musnier A; Poupon A; Cuturi MC; van Schooten W; Dalvi P
MAbs; 2022; 14(1):2095949. PubMed ID: 35867844
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD).
Yaku K; Okabe K; Gulshan M; Takatsu K; Okamoto H; Nakagawa T
Sci Rep; 2019 Sep; 9(1):13102. PubMed ID: 31511627
[TBL] [Abstract][Full Text] [Related]
32. NAD
Wagner S; Manickam R; Brotto M; Tipparaju SM
Mol Cell Biochem; 2022 Jun; 477(6):1829-1848. PubMed ID: 35334034
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity.
Wencel PL; Lukiw WJ; Strosznajder JB; Strosznajder RP
Mol Neurobiol; 2018 Jun; 55(6):4612-4623. PubMed ID: 28698968
[TBL] [Abstract][Full Text] [Related]
34. NAD⁺/NADH metabolism and NAD⁺-dependent enzymes in cell death and ischemic brain injury: current advances and therapeutic implications.
Ma Y; Nie H; Chen H; Li J; Hong Y; Wang B; Wang C; Zhang J; Cao W; Zhang M; Xu Y; Ding X; Yin SK; Qu X; Ying W
Curr Med Chem; 2015; 22(10):1239-47. PubMed ID: 25666794
[TBL] [Abstract][Full Text] [Related]
35. PARP is involved in replicative aging in Neurospora crassa.
Kothe GO; Kitamura M; Masutani M; Selker EU; Inoue H
Fungal Genet Biol; 2010 Apr; 47(4):297-309. PubMed ID: 20045739
[TBL] [Abstract][Full Text] [Related]
36. NAD⁺ in aging, metabolism, and neurodegeneration.
Verdin E
Science; 2015 Dec; 350(6265):1208-13. PubMed ID: 26785480
[TBL] [Abstract][Full Text] [Related]
37. ARTD1 (PARP1) activation and NAD(+) in DNA repair and cell death.
Fouquerel E; Sobol RW
DNA Repair (Amst); 2014 Nov; 23():27-32. PubMed ID: 25283336
[TBL] [Abstract][Full Text] [Related]
38. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.
Gariani K; Ryu D; Menzies KJ; Yi HS; Stein S; Zhang H; Perino A; Lemos V; Katsyuba E; Jha P; Vijgen S; Rubbia-Brandt L; Kim YK; Kim JT; Kim KS; Shong M; Schoonjans K; Auwerx J
J Hepatol; 2017 Jan; 66(1):132-141. PubMed ID: 27663419
[TBL] [Abstract][Full Text] [Related]
39. A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD
Tarragó MG; Chini CCS; Kanamori KS; Warner GM; Caride A; de Oliveira GC; Rud M; Samani A; Hein KZ; Huang R; Jurk D; Cho DS; Boslett JJ; Miller JD; Zweier JL; Passos JF; Doles JD; Becherer DJ; Chini EN
Cell Metab; 2018 May; 27(5):1081-1095.e10. PubMed ID: 29719225
[TBL] [Abstract][Full Text] [Related]
40. Sirtuins and their interactions with transcription factors and poly(ADP-ribose) polymerases.
Jęśko H; Strosznajder RP
Folia Neuropathol; 2016; 54(3):212-233. PubMed ID: 27764514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
